Does the media prefer IDXX or NVST?

In the previous week, IDEXX Laboratories had 10 more articles in the media than Envista. MarketBeat recorded 26 mentions for IDEXX Laboratories and 16 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.10 beat Envista's score of 0.96 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Envista 5 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, IDXX or SYK?

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IDEXX Laboratories $4.30B 10.78 $1.06B $13.58 43.32 Stryker $25.12B 5.12 $3.25B $9.65 34.72

Does the media refer more to IDXX or SYK?

In the previous week, Stryker had 28 more articles in the media than IDEXX Laboratories. MarketBeat recorded 54 mentions for Stryker and 26 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.10 beat Stryker's score of 0.75 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Stryker 20 Very Positive mention(s) 11 Positive mention(s) 12 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IDXX or ISRG?

In the previous week, Intuitive Surgical had 3 more articles in the media than IDEXX Laboratories. MarketBeat recorded 29 mentions for Intuitive Surgical and 26 mentions for IDEXX Laboratories. Intuitive Surgical's average media sentiment score of 1.15 beat IDEXX Laboratories' score of 1.10 indicating that Intuitive Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Intuitive Surgical 23 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to MDT or IDXX?

In the previous week, Medtronic and Medtronic both had 26 articles in the media. IDEXX Laboratories' average media sentiment score of 1.10 beat Medtronic's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 13 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Positive IDEXX Laboratories 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IDXX or BSX?

In the previous week, Boston Scientific had 10 more articles in the media than IDEXX Laboratories. MarketBeat recorded 36 mentions for Boston Scientific and 26 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.10 beat Boston Scientific's score of 0.88 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 21 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

IDEXX Laboratories (IDXX) Competitors

$588.26 +3.48 (+0.59%)

As of 03:20 PM Eastern

Compare

IDXX vs. NVST, SYK, ISRG, MDT, and BSX

Should you buy IDEXX Laboratories stock or one of its competitors? MarketBeat compares IDEXX Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IDEXX Laboratories include Envista (NVST), Stryker (SYK), Intuitive Surgical (ISRG), Medtronic (MDT), and Boston Scientific (BSX).

How does IDEXX Laboratories compare to Envista?

IDEXX Laboratories (NASDAQ:IDXX) and Envista (NYSE:NVST) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

87.8% of IDEXX Laboratories shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, IDEXX Laboratories had 10 more articles in the media than Envista. MarketBeat recorded 26 mentions for IDEXX Laboratories and 16 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.10 beat Envista's score of 0.96 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	5 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.78	$1.06B	$13.58	43.32
Envista	$2.81B	1.59	$47M	$0.41	67.00

IDEXX Laboratories currently has a consensus target price of $756.00, suggesting a potential upside of 28.52%. Envista has a consensus target price of $29.31, suggesting a potential upside of 6.68%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

IDEXX Laboratories has a net margin of 25.03% compared to Envista's net margin of 2.41%. IDEXX Laboratories' return on equity of 71.96% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Envista	2.41%	7.11%	3.91%

IDEXX Laboratories has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Summary

IDEXX Laboratories beats Envista on 13 of the 15 factors compared between the two stocks.

How does IDEXX Laboratories compare to Stryker?

IDEXX Laboratories (NASDAQ:IDXX) and Stryker (NYSE:SYK) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.78	$1.06B	$13.58	43.32
Stryker	$25.12B	5.12	$3.25B	$9.65	34.72

IDEXX Laboratories has a net margin of 25.03% compared to Stryker's net margin of 14.43%. IDEXX Laboratories' return on equity of 71.96% beat Stryker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Stryker	14.43%	23.63%	11.39%

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 77.1% of Stryker shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 4.6% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

IDEXX Laboratories has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market. Comparatively, Stryker has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

In the previous week, Stryker had 28 more articles in the media than IDEXX Laboratories. MarketBeat recorded 54 mentions for Stryker and 26 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.10 beat Stryker's score of 0.75 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Stryker	20 Very Positive mention(s)	11 Positive mention(s)	12 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories presently has a consensus price target of $756.00, suggesting a potential upside of 28.52%. Stryker has a consensus price target of $386.28, suggesting a potential upside of 15.29%. Given IDEXX Laboratories' higher possible upside, equities analysts plainly believe IDEXX Laboratories is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Stryker	0 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

IDEXX Laboratories beats Stryker on 10 of the 17 factors compared between the two stocks.

How does IDEXX Laboratories compare to Intuitive Surgical?

IDEXX Laboratories (NASDAQ:IDXX) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Intuitive Surgical has higher revenue and earnings than IDEXX Laboratories. Intuitive Surgical is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.78	$1.06B	$13.58	43.32
Intuitive Surgical	$11.03B	11.97	$2.86B	$8.73	42.83

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Intuitive Surgical has a net margin of 28.45% compared to IDEXX Laboratories' net margin of 25.03%. IDEXX Laboratories' return on equity of 71.96% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Intuitive Surgical	28.45%	16.91%	14.83%

IDEXX Laboratories presently has a consensus price target of $756.00, suggesting a potential upside of 28.52%. Intuitive Surgical has a consensus price target of $509.02, suggesting a potential upside of 36.15%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.66

IDEXX Laboratories has a beta of 1.54, meaning that its share price is 54% more volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

In the previous week, Intuitive Surgical had 3 more articles in the media than IDEXX Laboratories. MarketBeat recorded 29 mentions for Intuitive Surgical and 26 mentions for IDEXX Laboratories. Intuitive Surgical's average media sentiment score of 1.15 beat IDEXX Laboratories' score of 1.10 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Intuitive Surgical	23 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Intuitive Surgical beats IDEXX Laboratories on 10 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Medtronic?

Medtronic (NYSE:MDT) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Medtronic has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

In the previous week, Medtronic and Medtronic both had 26 articles in the media. IDEXX Laboratories' average media sentiment score of 1.10 beat Medtronic's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	13 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Positive
IDEXX Laboratories	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	3.03	$4.80B	$3.73	23.07
IDEXX Laboratories	$4.30B	10.78	$1.06B	$13.58	43.32

IDEXX Laboratories has a net margin of 25.03% compared to Medtronic's net margin of 13.20%. IDEXX Laboratories' return on equity of 71.96% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.51%	7.76%
IDEXX Laboratories	25.03%	71.96%	33.60%

Medtronic currently has a consensus target price of $98.83, suggesting a potential upside of 14.86%. IDEXX Laboratories has a consensus target price of $756.00, suggesting a potential upside of 28.52%. Given IDEXX Laboratories' higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

IDEXX Laboratories beats Medtronic on 11 of the 15 factors compared between the two stocks.

How does IDEXX Laboratories compare to Boston Scientific?

IDEXX Laboratories (NASDAQ:IDXX) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

IDEXX Laboratories has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Boston Scientific has higher revenue and earnings than IDEXX Laboratories. Boston Scientific is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.78	$1.06B	$13.58	43.32
Boston Scientific	$20.07B	3.57	$2.90B	$2.47	20.01

IDEXX Laboratories currently has a consensus target price of $756.00, suggesting a potential upside of 28.52%. Boston Scientific has a consensus target price of $71.62, suggesting a potential upside of 44.92%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

IDEXX Laboratories has a net margin of 25.03% compared to Boston Scientific's net margin of 17.50%. IDEXX Laboratories' return on equity of 71.96% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Boston Scientific	17.50%	19.28%	10.89%

In the previous week, Boston Scientific had 10 more articles in the media than IDEXX Laboratories. MarketBeat recorded 36 mentions for Boston Scientific and 26 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.10 beat Boston Scientific's score of 0.88 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	21 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IDEXX Laboratories beats Boston Scientific on 9 of the 16 factors compared between the two stocks.

Get IDEXX Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IDXX vs. The Competition

Export

Metric	IDEXX Laboratories	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$46.38B	$5.72B	$6.91B	$12.84B
Dividend Yield	N/A	1.78%	2.60%	9.78%
P/E Ratio	41.35	24.53	281.10	25.44
Price / Sales	10.78	59.69	571.60	79.78
Price / Cash	38.98	32.67	71.79	50.79
Price / Book	28.78	6.04	12.85	6.07
Net Income	$1.06B	$152.55M	$3.49B	$348.34M
7 Day Performance	5.27%	3.24%	2.48%	3.07%
1 Month Performance	4.12%	-1.80%	-2.81%	-3.04%
1 Year Performance	-5.76%	9.12%	75.60%	20.78%

IDEXX Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IDXX IDEXX Laboratories	4.0422 of 5 stars	$588.26 +0.6%	$756.00 +28.5%	-8.9%	$46.38B	$4.30B	41.35	11,000	Positive News Earnings Report Analyst Forecast
NVST Envista	2.2428 of 5 stars	$26.65 +1.2%	$28.54 +7.1%	+42.1%	$4.28B	$2.72B	64.99	12,000	Trending News Earnings Report Analyst Forecast
SYK Stryker	4.8822 of 5 stars	$337.31 +2.1%	$392.52 +16.4%	-11.4%	$126.60B	$25.12B	39.04	56,000	Earnings Report Dividend Announcement Analyst Forecast
ISRG Intuitive Surgical	4.7827 of 5 stars	$356.83 +5.7%	$519.13 +45.5%	-21.3%	$119.23B	$10.06B	40.87	17,021	Positive News
MDT Medtronic	4.8687 of 5 stars	$84.29 +1.3%	$98.21 +16.5%	-4.1%	$106.51B	$36.36B	22.60	95,000	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IDXX) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, SYK, ISRG, MDT, and BSX

How does IDEXX Laboratories compare to Envista?

Summary

How does IDEXX Laboratories compare to Stryker?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Summary

How does IDEXX Laboratories compare to Medtronic?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, SYK, ISRG, MDT, and BSX

How does IDEXX Laboratories compare to Envista?

Do institutionals and insiders have more ownership in IDXX or NVST?

Does the media prefer IDXX or NVST?

Which has better valuation and earnings, IDXX or NVST?

Do analysts rate IDXX or NVST?

Is IDXX or NVST more profitable?

Which has more volatility and risk, IDXX or NVST?

Summary

How does IDEXX Laboratories compare to Stryker?

Which has better valuation and earnings, IDXX or SYK?

Is IDXX or SYK more profitable?

Do institutionals and insiders hold more shares of IDXX or SYK?

Which has more risk & volatility, IDXX or SYK?

Does the media refer more to IDXX or SYK?

Do analysts recommend IDXX or SYK?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Which has preferable earnings & valuation, IDXX or ISRG?

Do insiders & institutionals have more ownership in IDXX or ISRG?

Is IDXX or ISRG more profitable?

Do analysts rate IDXX or ISRG?

Which has more volatility & risk, IDXX or ISRG?

Does the media favor IDXX or ISRG?

Summary

How does IDEXX Laboratories compare to Medtronic?

Do institutionals & insiders have more ownership in MDT or IDXX?

Which has more volatility and risk, MDT or IDXX?

Does the media refer more to MDT or IDXX?

Which has better earnings & valuation, MDT or IDXX?

Is MDT or IDXX more profitable?

Do analysts recommend MDT or IDXX?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Do institutionals & insiders hold more shares of IDXX or BSX?

Which has more volatility & risk, IDXX or BSX?

Which has higher valuation & earnings, IDXX or BSX?

Do analysts prefer IDXX or BSX?

Is IDXX or BSX more profitable?

Does the media favor IDXX or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools